Weight Loss Drug Maker Latest To Pull IPO Amid Weak Market
Weight-loss capsule developer Gelesis Inc. on Thursday withdrew plans for a $52 million initial public offering over concerns about current market conditions, the latest in a string of companies that have...To view the full article, register now.
Already a subscriber? Click here to view full article